MAP2 and Alzheimer disease: On the contrary, the administration of M2 microglia‐derived exosomes (M2‐Exos) in AD cell models (HT‐22 cells and MAP2‐positive neuronal cells of APP/PS1 AD mice models) reduced Aβ plaque deposition and oligomer expression, partially improved cell viability, and restored the mitochondrial membrane potential.